|
11 Sep 2023
|
3B BlackBio Dx
|
Edelweiss
|
1434.40
|
1184.00
|
840.30
(70.70%)
|
Target met |
Buy
|
|
|
Kilpest India (KLPI) has seen multiple transformations in the last ~50 years of existence.
|
|
07 Sep 2023
|
Kewal Kiran Clothing
|
Edelweiss
|
502.65
|
|
657.95
(-23.60%)
|
|
Not Rated
|
|
|
A beautiful tapestry
|
|
05 Sep 2023
|
Commercial Serv. & Supplies
|
Edelweiss
|
|
|
|
|
Sector Update
|
|
|
Moving to the Next Orbit
|
|
03 Sep 2023
|
Beta Drugs
|
Edelweiss
|
1874.00
|
1325.00
|
999.95
(87.41%)
|
Target met |
Buy
|
|
|
Beta Drugs (BETADR) is one of the leading players in the domestic oncology space and ranks among the top 10 in the cytotoxic market.
|
|
31 Aug 2023
|
Indian Economy
|
Edelweiss
|
|
|
|
|
Economy Update
|
|
|
Credit offtake accelerates in July
|
|
29 Aug 2023
|
Realty
|
Edelweiss
|
|
|
|
|
Sector Update
|
|
|
The buoyancy continues
|
|
28 Aug 2023
|
Repco Home Finance
|
Edelweiss
|
346.80
|
|
391.35
(-11.38%)
|
|
Not Rated
|
|
|
Road to recovery
|
|
18 Aug 2023
|
Globus Spirits
|
Edelweiss
|
1204.50
|
1146.00
|
925.75
(30.11%)
|
|
Buy
|
|
|
Growth may moderate amid disruptions
|
|
17 Aug 2023
|
Vinati Organics
|
Edelweiss
|
1710.40
|
1934.00
|
1813.75
(-5.70%)
|
Target met |
Buy
|
|
|
Weak performance owing to subdued demand for ATBS
|
|
16 Aug 2023
|
KNR Constructions
|
Edelweiss
|
190.88
|
300.00
|
242.60
(-21.32%)
|
Target met |
Buy
|
|
|
Order book build up critical; diversification on the cards
|